Balaji Amines (530999) Hisse Özeti
Balaji Amines Limited, Hindistan'da metilaminler, etilaminler ve özel kimyasalların türevleri ve ilaç eksipiyanlarının üretimi ve satışı ile uğraşmaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 1/6 |
| Gelecekteki Büyüme | 3/6 |
| Geçmiş Performans | 4/6 |
| Finansal Sağlık | 6/6 |
| Temettüler | 4/6 |
530999 Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Balaji Amines Limited Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | ₹2,082.90 |
| 52 Haftanın En Yüksek Seviyesi | ₹2,443.15 |
| 52 Haftanın En Düşük Seviyesi | ₹905.15 |
| Beta | 0.85 |
| 1 Aylık Değişim | -11.17% |
| 3 Aylık Değişim | 28.37% |
| 1 Yıllık Değişim | 33.29% |
| 3 Yıllık Değişim | -1.18% |
| 5 Yıllık Değişim | -38.76% |
| Halka arzdan bu yana değişim | 16,516.67% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • Jul 23
530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside
The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.
Anlatı Güncellemesi • Jul 09
530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure
Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.Recent updates
Anlatı Güncellemesi • Jul 23
530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside
The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.Anlatı Güncellemesi • Jul 09
530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure
Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.Anlatı Güncellemesi • Jun 18
530999: Higher P E And Weaker Margins Will Pressure Future Returns
Analysts have raised their price target on Balaji Amines to ₹1,494 from ₹1,334, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Balaji Amines Balaji Amines has scheduled a board meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.Anlatı Güncellemesi • May 21
530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism
Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
Anlatı Güncellemesi • May 07
530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside
Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.Anlatı Güncellemesi • Apr 23
530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside
Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.Anlatı Güncellemesi • Apr 08
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Anlatı Güncellemesi • Mar 24
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.Anlatı Güncellemesi • Mar 10
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Anlatı Güncellemesi • Feb 23
530999: Higher Future P E And Margins Will Likely Support Returns
Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.Anlatı Güncellemesi • Feb 09
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Anlatı Güncellemesi • Jan 25
530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins
Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Anlatı Güncellemesi • Jan 10
530999: Stable Margins And Upcoming Results Will Support Further Upside
Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).Anlatı Güncellemesi • Dec 25
530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins
Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.Anlatı Güncellemesi • Dec 11
530999: Stable Margins And Growth Outlook Will Support Further Upside
Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Anlatı Güncellemesi • Nov 27
530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales
Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.Anlatı Güncellemesi • Sep 05
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
Yeni Anlatı • Feb 02
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.Hissedar Getirileri
| 530999 | IN Chemicals | IN Pazar | |
|---|---|---|---|
| 7D | 4.1% | 0.4% | 0.3% |
| 1Y | 33.3% | 1.3% | 5.2% |
Getiri vs. Endüstri: 530999 geçen yıl % 1.3 oranında getiri sağlayan Indian Chemicals sektörünü aştı.
Getiri vs Piyasa: 530999 geçen yıl % 5.2 oranında getiri sağlayan Indian Piyasasını aştı.
Fiyat Oynaklığı
| 530999 volatility | |
|---|---|
| 530999 Average Weekly Movement | 10.7% |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.7% |
İstikrarlı Hisse Senedi Fiyatı: 530999 hisse senedi fiyatı, son 3 ayda Indian piyasasına kıyasla dalgalı seyretti.
Zaman İçindeki Volatilite: 530999 'nin haftalık oynaklığı ( 11% ) geçen yıl boyunca sabit kaldı, ancak hala Indian hisselerinin %75'inden yüksek.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1988 | 1,161 | Dundurapu Reddy | www.balajiamines.com |
Balaji Amines Limited, Hindistan'da metilaminler, etilaminler ve özel kimyasalların türevleri ve ilaç eksipiyanlarının üretimi ve satışı ile uğraşmaktadır. Şirket, Kimyasallar ve Otel olmak üzere iki segmentte faaliyet göstermektedir. Monometilamin, dimetilamin, trimetilamin, monoetilamin, dietilamin, trietilamin ve dimetil ve dietil amino etanol; ve N-metil pirolidon, morfolin, 2-pirolidon, N-etil-2-pirolidon, gama-bütirolakton, dimetilformamid, asetonitril, dimetilkarbonat, propilen glikol ve propilen karbonat dahil olmak üzere özel kimyasallar sunmaktadır.
Balaji Amines Limited Temel Bilgiler Özeti
| 530999 temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | ₹67.49b |
| Kazançlar(TTM) | ₹2.04b |
| Gelir(TTM) | ₹15.23b |
33.1x
F/K Oranı4.4x
P/S Oranı530999 aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| 530999 gelir tablosu (TTM) | |
|---|---|
| Gelir | ₹15.23b |
| Gelir Maliyeti | ₹8.44b |
| Brüt Kâr | ₹6.78b |
| Diğer Giderler | ₹4.74b |
| Kazançlar | ₹2.04b |
Son Raporlanan Kazançlar
Jun 30, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | 63.00 |
| Brüt Marj | 44.54% |
| Net Kâr Marjı | 13.41% |
| Borç/Özkaynak Oranı | 6.2% |
530999 uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
0.5%
Mevcut Temettü Verimi21%
Ödeme OranıŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/08/12 18:43 |
| Gün Sonu Hisse Fiyatı | 2026/08/12 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2026/03/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Balaji Amines Limited 4 Bu analistlerden 2, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Nilesh Ghuge | HDFC Securities Limited |
| Jay Gandhi | HDFC Securities Limited |
| Keshav Lahoti | HDFC Securities Limited |